Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesPodcastsPodcast: What's next for chest radiographs?In this episode of Keeping up with the Radiologists, co-hosts Saurabh (Harry) Jha, MD, and Mitchell Schnall, MD, assess the future of the chest radiograph.InterventionalThermal ablation effective long term in patients with thyroid cancerUltrasoundCould cranial ultrasound sub for brain MRI in imaging infants?Digital X-RayDark-field x-ray detects bone changes related to osteoporosisSponsor ContentFREE Webinar